Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
XBC.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XBC.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.2 (Alpha)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Q.2 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BL.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
M.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
M.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
C.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.82 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.82 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.30EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
A.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.35EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.36.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.23.1 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.23.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.466.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.466.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.213EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.213EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.8 (Alpha)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Q.8 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.122.1 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.122.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.5.6 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.5.6 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.440EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.440EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BZ.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.34EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.129 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.129 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.2.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used